MMEDF News and Press, Mind Medicine From 04/28/21

A clinical-stage psychedelic medicine biotech company, Mind Medicine Inc. (MMEDF), has benefited from growing demand for therapies for people with mental disorders. However, several headwinds related to FDA approval and uncertainties surrounding its commercialization prospects could lead to a...

NEW YORK, April 27, 2021 /PRNewswire/ — Mind Medicine (MindMed) Inc. (NEO: MMED)(DE: BGHM)(OTCQB:MMEDF), a leading psychedelic medicine biotech company, is pleased to announce the start of trading on The Nasdaq Capital Market (“Nasdaq”). Trading will ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Monday trading may be over, but make sure you are all caught up and ready for the week. To start, what did the stock market do today? And what else should be on your radar? Source: Shutterstock The S&P 500 c...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips What Happened to the COMPASS Pathways Stock Price Today? Source: Shutterstock Shares of psychedelics-inspired medicine developer COMPASS Pathways (NASDAQ: CMPS ) jumped more than 5% on Monday, continuing wha...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips MindMed (OTCMKTS: MMEDF ) stock has been climbing recently in anticipation of its uplisting on the Nasdaq Exchange this week, where it will trade as MNMD stock. The company’s announcement that it will be h...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips News that MindMed  (OTCMKTS: MMEDF ) stock will uplist to the Nasdaq Exchange next week is boosting sector peers including Numinus Wellness  (OTCMKTS: LKYSF ) and Champignon Brands (OTCMKTS: SHRMF ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips MindMed (OTCMKTS: MMEDF ) stock was getting high on Friday as the penny stock prepares for an uplisting to the Nasdaq Exchange from the OTC Markets . Source: luckakcul / Shutterstock.com So when exactly can...

MindMed (MMEDF) announced that its subordinate voting shares have been approved for listing on The Nasdaq; trading is expected to commence on Apr.27 under the symbol, 'MNMD'.MindMed will retain its listing on the Neo Exchange under the symbol "MMED" and the company's subordinate voting s...

MindMed To Commence Trading on Nasdaq PR Newswire NEW YORK , April 23, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading psychedelic medicine biotech company, announced today that the Company's subordinate voting shares have been a...

The psychedelics investment proposition is an enticing one for investors, and the bedrock of the industry is the potential attached to clinical research on psychedelic substances. Thanks to the groundbreaking progress of studies and trials evaluating psychedelic treatments, the enti...